Harvey H Hensley

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice
    Harvey H Hensley
    Biological Imaging Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Neoplasia 14:451-62. 2012
  2. ncbi Endoscopic imaging and size estimation of colorectal adenomas in the multiple intestinal neoplasia mouse
    Harvey H Hensley
    Divisions of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Gastrointest Endosc 69:742-9. 2009
  3. ncbi Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity
    Margie L Clapper
    Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Neoplasia 13:685-91. 2011
  4. ncbi RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
    Seiji Mabuchi
    Human Genetics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 13:4261-70. 2007
  5. ncbi RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
    Seiji Mabuchi
    Human Genetics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 67:2408-13. 2007
  6. ncbi Xenograft and transgenic mouse models of epithelial ovarian cancer and non-invasive imaging modalities to monitor ovarian tumor growth in situ: applications in evaluating novel therapeutic agents
    Denise C Connolly
    Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Curr Protoc Pharmacol . 2009
  7. ncbi Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging
    Harvey H Hensley
    Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Magn Reson Med 52:524-9. 2004

Detail Information

Publications7

  1. ncbi Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice
    Harvey H Hensley
    Biological Imaging Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Neoplasia 14:451-62. 2012
    ....
  2. ncbi Endoscopic imaging and size estimation of colorectal adenomas in the multiple intestinal neoplasia mouse
    Harvey H Hensley
    Divisions of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Gastrointest Endosc 69:742-9. 2009
    ..The scientific potential of animal models of carcinogenesis has not been fully realized because of our limited ability to monitor tumor growth in vivo...
  3. ncbi Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity
    Margie L Clapper
    Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Neoplasia 13:685-91. 2011
    ..Use of this fluorescent probe in combination with colonoscopy could aid in preventing colorectal neoplasias by providing new opportunities for early detection and therapeutic intervention...
  4. ncbi RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
    Seiji Mabuchi
    Human Genetics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Clin Cancer Res 13:4261-70. 2007
    ..We examined whether mTOR inhibition by RAD001 (everolimus) is therapeutically efficacious in the treatment of ovarian cancer as a single agent and in combination with cisplatin...
  5. ncbi RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
    Seiji Mabuchi
    Human Genetics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Cancer Res 67:2408-13. 2007
    ....
  6. ncbi Xenograft and transgenic mouse models of epithelial ovarian cancer and non-invasive imaging modalities to monitor ovarian tumor growth in situ: applications in evaluating novel therapeutic agents
    Denise C Connolly
    Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Curr Protoc Pharmacol . 2009
    ....
  7. ncbi Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging
    Harvey H Hensley
    Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Magn Reson Med 52:524-9. 2004
    ..942, and a P-value of 0.008, based on Spearman's test. These data show that MRI can be used to accurately monitor tumor growth in mouse models of colorectal carcinogenesis...